Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

98 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

NCT03219268

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +48 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 40 locations
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN

NCT05802290

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Ospedale Papa Giovanni XXIII Bergamo, Italy
  • Ospedale Bellaria Bologna, Italy
  • IRCCS di Candiolo Candiolo, Italy
  • Azienda Ospedaliera S. Croce E Carle Di Cuneo - Cuneo (Cn) Oncoematologia Cuneo, Italy
View all 23 locations
View Trial Details
Completed

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

NCT01353625

Conditions
Astrocytoma, Blood Protein Disorders, Carcinoma, +52 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details

Related conditions